Randomized, Double Blinded, Placebo-Controlled, Phase 2 Study of Safety, Tolerability and Efficacy of Pirfenidone in Patients with Rheumatoid Arthritis Interstitial Lung Disease

被引：0
|
作者：
Rosas, I. [1 ]
Solomon, J. [2 ]
Donoff, S. [3 ]
Woodhead, F. [4 ]
Raghu, G. [5 ]
Hilary, G. [6 ]
机构：
[1] Baylor Coll Med, Houston, TX 77030 USA
[2] Univ Colorado, Denver, CO 80202 USA
[3] Johns Hopkins Univ Hosp, Baltimore, MD 21287 USA
[4] Univ Leicester, Leicester, Leics, England
[5] Univ Washington, Seattle, WA 98195 USA
[6] Brigham & Womens Hosp, 75 Francis St, Boston, MA 02115 USA
[7] TRAIL NETWORK, Seattle, WA USA
来源：
EUROPEAN RESPIRATORY JOURNAL | 2022年 / 60卷
关键词：
D O I：
10.1183/13993003.congress-2022.4534
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
4534
引用
收藏
页数：2
相关论文
共 50 条
  • [21] A Randomized Double Blinded Placebo Controlled Study of Probiotics in Active Rheumatoid Arthritis (RA)
    Pineda, Maria
    Thompson, Sarah
    Reid, Gregor
    De Leon, Faye
    Pope, Janet
    JOURNAL OF RHEUMATOLOGY, 2010, 37 (06) : 1305 - 1305
  • [22] Efficacy and safety of ixekizumab in a randomized, double-blinded, placebo-controlled phase IIIb study of patients with moderate-to-severe genital psoriasis
    Ryan, C.
    Menter, A.
    Guenther, L.
    Blauvelt, A.
    Bissonnette, R.
    Meeuwis, K.
    Sullivan, J.
    Cather, J. C.
    Yosipovitch, G.
    Gottlieb, A. B.
    Merola, J. F.
    Duffin, K. Callis
    Fretzin, S.
    Osuntokun, O. O.
    Burge, R.
    Naegeli, A. N.
    Yang, F. E.
    Lin, C. -Y.
    Todd, K.
    Bleakman, A. Potts
    BRITISH JOURNAL OF DERMATOLOGY, 2018, 179 (04) : 844 - 852
  • [23] Bimekizumab efficacy and safety in Korean patients with moderate to severe plaque psoriasis: A phase 3, randomized, placebo-controlled, double-blinded study
    Youn, Sang Woong
    Jo, Seong Jin
    Park, Chul Jong
    Kim, Dong Hyun
    Shin, Bong Seok
    Jeong, Ki Heon
    Bang, Chul Hwan
    Cross, Nancy
    Thirlwell, Jackie
    Hoepken, Bengt
    JOURNAL OF DERMATOLOGY, 2024,
  • [24] A randomized double-blind placebo-controlled phase 2 study on the efficacy and safety of fasudil in patients with stable angina
    Vicari, RM
    Chaitman, B
    Keefe, D
    Smith, WB
    Chrysant, ST
    Tonkon, MJ
    Bittar, N
    Weiss, RJ
    Thadani, U
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2004, 43 (05) : 254A - 254A
  • [25] Clinical efficacy and tolerability evaluation of pentoxifylline in rheumatoid arthritis - A double-blind, randomised, placebo-controlled study
    Usha, PR
    Naidu, MUR
    Datla, R
    CLINICAL DRUG INVESTIGATION, 2002, 22 (05) : 329 - 339
  • [26] A Phase 2 Randomized, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Talactoferrin in Patients With Severe Sepsis
    Guntupalli, Kalpalatha
    Dean, Nathan
    Morris, Peter E.
    Bandi, Venkata
    Margolis, Benjamin
    Rivers, Emanuel
    Levy, Mitchell
    Lodato, Robert F.
    Ismail, Preeti M.
    Reese, Amber
    Schaumberg, John P.
    Malik, Rajesh
    Dellinger, R. Phillip
    CRITICAL CARE MEDICINE, 2013, 41 (03) : 706 - 716
  • [27] A randomized, placebo-controlled, phase 2 study of the efficacy and safety of droxidopa in patients with intradialytic hypotension
    Vannorsdall, Mark D.
    Hariachar, Srinivas
    Hewitt, L. Arthur
    POSTGRADUATE MEDICINE, 2015, 127 (02) : 133 - 143
  • [28] Evaluation of the safety, tolerability, and efficacy of pimavanserin versus placebo in patients with Alzheimer's disease psychosis: a phase 2, randomised, placebo-controlled, double-blind study
    Ballard, Clive
    Banister, Carol
    Khan, Zunera
    Cummings, Jeffrey
    Demos, George
    Coate, Bruce
    Youakim, James M.
    Owen, Randall
    Stankovic, Srdjan
    LANCET NEUROLOGY, 2018, 17 (03): : 213 - 222
  • [29] Efficacy and Safety of Tangshen Formula on Patients with Type 2 Diabetic Kidney Disease: A Multicenter Double-Blinded Randomized Placebo-Controlled Trial
    Li, Ping
    Chen, Yiping
    Liu, Jianping
    Hong, Jing
    Deng, Yueyi
    Yang, Fang
    Jin, Xiuping
    Gao, Jing
    Li, Jing
    Fang, Hui
    Liu, Geling
    Shi, Liping
    Du, Jinhang
    Li, Yang
    Yan, Meihua
    Wen, Yumin
    Yang, Wenying
    PLOS ONE, 2015, 10 (05):
  • [30] A randomized, double-blind, placebo-controlled phase 2 study to assess safety, tolerability, and efficacy of RT001 in patients with amyotrophic lateral sclerosis
    Weemering, Daphne N.
    Midei, Mark
    Milner, Peter
    Gopalakrishnan, Vidhya
    Kumar, Anil
    Dannenberg, Andrew J.
    Bunte, Tommy M.
    Foucher, Juliette
    Ingre, Caroline
    Kenina, Viktorija
    Rallmann, Karin
    van den Berg, Leonard H.
    van Eijk, Ruben P. A.
    EUROPEAN JOURNAL OF NEUROLOGY, 2023, 30 (12) : 3722 - 3731
12345